Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26 tags : Biotech-bay save search
DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
DRRX | $0.8781 12.36% 11.0% 140K
|
Health Technology
|
| O: -1.69%
H: 4.76%
C: 2.67%
corporation financial update results
Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
BTCY | $1.25 4.17% 4.0% 87K
|
Manufacturing
|
| O: -1.87%
H: 9.52%
C: 5.71%
management disease cardiac
Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: 0.76%
H: 10.38%
C: 9.62%
vaccine breast trial cancer phase 2b
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.